Genlantis, a division of Gene Therapy Systems, Inc., is focused on developing innovative reagents for transfection, gene expression, Gene Silencing, RNA interference, primary cell culture, lab sterilization equipment, and sample preparation in proteomics research. We are dedicated to serving the needs of life science researchers worldwide by embracing innovation.